List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
506-MA-1001A multi-center, randomized, open-label, pilot and exploratory study investigating safety and efficacy in OPTIMIZEd dosing of Advagraf® kidney transplantation in Asia. English


English


ACNKTxConA randomized, open-label, multi-center clinical trial to compare efficacy and safety of cyclosporine-based and switching cyclosporine to tacrolimus of two forms-based immunosuppressive therapy in renal transplant (KTx) recipients. English


English


ADV-KT-02-KORA Multicenter, Open-label, Single-arm, Non-inferiority Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, based Immunosuppressive Regimen in Stable Kidney Transplant Patients Converted from a PROGRAF® based Immunosuppressive Regimen English


English


ADV-KT-13-01A Multicenter, Randomized, Comparison, Open-label, Phase IV Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients English


English


NextLast

QUICK SEARCH

USEFUL LINKS